{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:16:41Z","timestamp":1783160201222,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20230807110406013"],"award-info":[{"award-number":["JCYJ20230807110406013"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20210733"],"award-info":[{"award-number":["BK20210733"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["ZXL2021447"],"award-info":[{"award-number":["ZXL2021447"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22101194"],"award-info":[{"award-number":["22101194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012462","name":"Collaborative Innovation Center of Suzhou Nano Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.actbio.2026.04.031","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:04:55Z","timestamp":1776755095000},"page":"461-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modulation of intrabone distribution of anionic polypeptide nanocarriers through hydrophobic modification for the treatment of acute myeloid leukemia"],"prefix":"10.1016","volume":"216","author":[{"given":"Wanying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3165-3712","authenticated-orcid":false,"given":"Ziyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.04.031_bib0001","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.actbio.2026.04.031_bib0002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.actbio.2026.04.031_bib0003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrendo.2015.71","article-title":"Short-term and long-term effects of osteoporosis therapies","volume":"11","author":"Reid","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0004","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0005","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0140-6736(20)32340-0","article-title":"Global estimates of the need for rehabilitation based on the global burden of disease study 2019: a systematic analysis for the global burden of disease Study 2019","volume":"396","author":"Cieza","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2026.04.031_bib0006","doi-asserted-by":"crossref","first-page":"n2026","DOI":"10.1136\/bmj.n2026","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"Br. Med. J."},{"key":"10.1016\/j.actbio.2026.04.031_bib0007","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.addr.2012.01.012","article-title":"Targeting polymer therapeutics to bone","volume":"64","author":"Low","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2026.04.031_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2017.11.009","article-title":"Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics","volume":"269","author":"Rotman","year":"2018","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2026.04.031_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41584-022-00764-w","article-title":"Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases","volume":"18","author":"So\u00f3s","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.137133","article-title":"Bone-targeted biomaterials: strategies and applications","volume":"446","author":"Ren","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.actbio.2026.04.031_bib0011","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41392-023-01467-8","article-title":"Targeting strategies for bone diseases: signaling pathways and clinical studies","volume":"8","author":"Xu","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.actbio.2026.04.031_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41568-022-00546-2","article-title":"Therapeutic targeting of tumour myeloid cells","volume":"23","author":"Barry","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2026.04.031_bib0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.actbio.2022.11.007","article-title":"Amplifying STING activation by bioinspired nanomedicine for targeted chemo- and immunotherapy of acute myeloid leukemia","volume":"157","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.031_bib0014","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1073\/pnas.1401337111","article-title":"Engineered nanomedicine for myeloma and bone microenvironment targeting","volume":"111","author":"Swami","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2026.04.031_bib0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nm.3791","article-title":"Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy","volume":"21","author":"Liang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2026.04.031_bib0016","doi-asserted-by":"crossref","first-page":"40163","DOI":"10.1021\/acsami.3c05184","article-title":"EGTA-derived carbon dots with bone-targeting ability: target-oriented synthesis and calcium affinity","volume":"15","author":"Liu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces."},{"key":"10.1016\/j.actbio.2026.04.031_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.213924","article-title":"Alendronate\/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia","volume":"162","author":"Abou-Elnour","year":"2024","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.actbio.2026.04.031_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123516","article-title":"Bone marrow microenvironment-responsive polymeric-drug\/siRNA regulates leukemia stem cells assisting for prevention of AML relapse","volume":"324","author":"Cheng","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.04.031_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120345","article-title":"Bone-targeting polymer vesicles for simultaneous imaging and effective malignant bone tumor treatment","volume":"269","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.04.031_bib0020","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1021\/acs.nanolett.1c02150","article-title":"Bone-targeting polymer vesicles for effective therapy of osteoporosis","volume":"21","author":"Zhou","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2026.04.031_bib0021","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1039\/D4BM00437J","article-title":"Effects of chain lengths and backbone chirality on the bone-targeting ability of poly(glutamic acid)s","volume":"12","author":"Xia","year":"2024","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2026.04.031_bib0022","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1021\/acs.biomac.4c01714","article-title":"Enhanced bone targeting of poly(L-glutamic acid)s through cationic or aromatic substitution","volume":"26","author":"Jin","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2026.04.031_bib0023","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41408-021-00414-6","article-title":"A clinical perspective on plasma cell leukemia; current status and future directions","volume":"11","author":"Tuazon","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.actbio.2026.04.031_bib0025","doi-asserted-by":"crossref","first-page":"eabg3217","DOI":"10.1126\/sciadv.abg3217","article-title":"Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy","volume":"7","author":"Ho","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.04.031_bib0026","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1039\/D1CS00755F","article-title":"Delivery strategies in treatments of leukemia","volume":"51","author":"Ci","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2026.04.031_bib0027","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","article-title":"Towards precision medicine for AML","volume":"18","author":"D\u00f6hner","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.actbio.2024.08.053","article-title":"Lipopolymer\/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia","volume":"188","author":"Ansari","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.04.031_bib0029","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1038\/s41467-021-25689-y","article-title":"A moisture-tolerant route to unprotected \u03b1\/\u03b2-amino acid N-carboxyanhydrides and facile synthesis of hyperbranched polypeptides","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2026.04.031_bib0030","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1039\/C6PY02230H","article-title":"Investigation on the controlled synthesis and post-modification of poly-[(N-2-hydroxyethyl)-aspartamide]-based polymers","volume":"8","author":"Lv","year":"2017","journal-title":"Polym. Chem."},{"key":"10.1016\/j.actbio.2026.04.031_bib0031","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/1061186X.2011.622402","article-title":"Novel star HPMA-based polymer conjugates for passive targeting to solid tumors","volume":"19","author":"Etrych","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.actbio.2026.04.031_bib0032","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","article-title":"Polymer-drug conjugate therapeutics: advances, insights and prospects","volume":"18","author":"Ekladious","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2026.04.031_bib0033","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1039\/c2py20327h","article-title":"Star polypeptides by NCA polymerisation from dendritic initiators: synthesis and enzyme controlled payload release","volume":"3","author":"Byrne","year":"2012","journal-title":"Polym. Chem."},{"key":"10.1016\/j.actbio.2026.04.031_bib0034","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/acsnano.4c11719","article-title":"Rigid, \u03b1-helical polypeptide nanoprobes with thermally activated delayed fluorescence for time-resolved, high-contrast bioimaging","volume":"19","author":"Chu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.04.031_bib0035","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1021\/acs.macromol.3c00704","article-title":"Polymerization of N-carboxyanhydride in cosolvents: the balance between the polymerization rate and molecular weight control","volume":"56","author":"Li","year":"2023","journal-title":"Macromolecules"},{"key":"10.1016\/j.actbio.2026.04.031_bib0036","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1182\/blood.V108.11.4513.4513","article-title":"Extramedullary infiltrates of AML: biological and clinical features in a single centre experience","volume":"108","author":"Carluccio","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2026.04.031_bib0037","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41375-024-02337-0","article-title":"Clinical and molecular characteristics of extramedullary acute myeloid leukemias","volume":"38","author":"Kewan","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.actbio.2026.04.031_bib0038","doi-asserted-by":"crossref","first-page":"20825","DOI":"10.1021\/acsnano.3c05853","article-title":"Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and clearance","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.04.031_bib0039","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1038\/s41467-021-26808-5","article-title":"Tunable, biodegradable grafting-from glycopolypeptide bottlebrush polymers","volume":"12","author":"Clauss","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2026.04.031_bib0040","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1021\/acs.jpcc.7b12142","article-title":"Essence of small molecule-mediated control of hydroxyapatite growth: free energy calculations of amino acid side chain analogues","volume":"122","author":"Xu","year":"2018","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.actbio.2026.04.031_bib0041","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.leu.2402740","article-title":"FLT3 mutations in acute myeloid leukemia cell lines","volume":"17","author":"Quentmeier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.actbio.2026.04.031_bib0042","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13045-018-0675-4","article-title":"FLT3 inhibitors in acute myeloid leukemia","volume":"11","author":"Wu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104367","article-title":"Targeting FLT3 for treating diseases: FLT3 inhibitors","volume":"30","author":"Rong","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actbio.2026.04.031_bib0044","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/ma00201a029","article-title":"Block copolymer self-assembly in selective solvents: theory of solubilization in spherical micelles","volume":"22","author":"Nagarajan","year":"1989","journal-title":"Macromolecules"},{"key":"10.1016\/j.actbio.2026.04.031_bib0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s00223-012-9570-0","article-title":"Bisphosphonate binding affinity affects drug distribution in both intracortical and trabecular bone of rabbits","volume":"90","author":"Turek","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.actbio.2026.04.031_bib0046","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/smll.201200794","article-title":"The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles","volume":"8","author":"Zhu","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.actbio.2026.04.031_bib0047","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1182\/blood.V128.22.2662.2662","article-title":"Increased vascular permeability in the bone marrow microenvironment contributes to acute myeloid leukemia progression and drug response","volume":"128","author":"Passaro","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2026.04.031_bib0048","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41568-023-00574-6","article-title":"Endocytosis in cancer and cancer therapy","volume":"23","author":"Banushi","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2026.04.031_bib0049","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1021\/acsabm.3c00236","article-title":"Size control and biological properties of PAMAM-cored multiarm block copolymers","volume":"6","author":"Yu","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.actbio.2026.04.031_bib0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2141.2004.05145.x","article-title":"The expression of P-glycoprotein in AML cells with FLT3 internal tandem duplications is associated with reduced apoptosis in response to FLT3 inhibitors","volume":"127","author":"Hunter","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.actbio.2026.04.031_bib0051","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/bloodadvances.2018022921","article-title":"Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3\/ITD AML from tyrosine kinase inhibitors","volume":"3","author":"Chang","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.actbio.2026.04.031_bib0052","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40262-020-00888-w","article-title":"Pharmacokinetic profile of gilteritinib: a novel FLT-3 tyrosine kinase inhibitor","volume":"59","author":"James","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.actbio.2026.04.031_bib0053","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1038\/bcj.2015.19","article-title":"A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia","volume":"5","author":"Saland","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.actbio.2026.04.031_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117089","article-title":"Identification of inhibitors targeting the FLT3-ITD mutation through 4D-QSAR, in vitro, and in silico","volume":"282","author":"Chu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actbio.2026.04.031_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204866","article-title":"Codelivery of BCL2 and MCL1 inhibitors enabled by phenylboronic acid-functionalized polypeptide nanovehicles for synergetic and potent therapy of acute myeloid leukemia","volume":"10","author":"Xie","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2026.04.031_bib0056","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nm.3364","article-title":"Differential regulation of myeloid leukemias by the bone marrow microenvironment","volume":"19","author":"Krause","year":"2013","journal-title":"Nat. Med."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:30:29Z","timestamp":1783157429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126002503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S1742706126002503"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.031","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of intrabone distribution of anionic polypeptide nanocarriers through hydrophobic modification for the treatment of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}